Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial.

Alicia Marín-CandónClara M Rosso-FernándezNatalia Bustos de GodoyLorena López-CereroBelén Gutiérrez-GutiérrezLuis Eduardo López-CortésLydia Barrera PulidoIrene Borreguero BorregueroMaría José LeónVicente MerinoManuel Camean-FernándezPilar RetamarElena SalamancaAlvaro PascualJesús Rodriguez-Bañonull null

Published in: BMJ open (2021)

NCT04478721.

Keyphrases

study protocol
clinical trial
randomized controlled trial
gram negative
open label
phase iii
cancer therapy
placebo controlled